Speaker(s): 

Catherine McCarthy MD, FAAFP, Professor Family Medicine, University of Nevada, Reno School of Medicine (has nothing to disclose)

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the purpose and scope of the Healthy Nevada Project and its approach to integrating genomic data into clinical care.
• Identify key genetic conditions prioritized in the HNP population screening program, CDC Tier 1 conditions (e.g., BRCA1/2, Lynch syndrome, familial hypercholesterolemia).
• Explain how actionable genetic findings are returned and managed in our clinical setting.
• Discuss specific patient cases that illustrate the utility, challenges, and ethical considerations of genomic screening in practice.
• Recognize the implications of population genomics for public health, patient engagement, and the future of precision medicine.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Adam Buchanan, MS, MPH, LCGC, Juliann Savatt, MS, LCGC, Melissa Kelly, MS, LCGC, Marc Williams, MD, and Cara McCormick, MPH have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose: Dan Dometita, DO and Sara Gaines, PharmD

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None